2021

1. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment

   AMERICAN JOURNAL OF CANCER RESEARCH, Vol. 11, Núm. 9, pp. 4438-4456

2. Proliferation to apoptosis tumor cell ratio as a biomarker to improve clinical management of pre-malignant and symptomatic plasma cell neoplasms

   International Journal of Molecular Sciences, Vol. 22, Núm. 8